Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 2,409 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Invasive Procedure Clear all

Conditions: Multiple Sclerosis
Interventions: Transcutaneous electrical spinal cord stimulation + therapy, Occupational Therapy; Combination Product · Other
Lead sponsor: University of Washington; Other
Eligibility: 21 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hysterectomy, Gynecologic Surgical Procedures, Narcotic Use, Pain, Postoperative
Interventions: Ropivacaine Infusion from ON-Q Pump, Ropivacaine + Ketorolac Infusion from ON-Q Pump, Normal Saline Infusion from ON-Q Pump; Drug
Lead sponsor: Ying Liu; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Washington D.C., District of Columbia

Conditions: Irregular Heart Rate
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder
Interventions: UGN-102; Drug
Lead sponsor: UroGen Pharma Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 5
States / cities: Homewood, Alabama • Indianapolis, Indiana • Greensboro, North Carolina + 2 more

Conditions: Intraoperative Ureter Visualization, Abdominolpelvic Surgery
Interventions: pudexacianinium chloride; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 6
States / cities: Orlando, Florida • Tampa, Florida • Weston, Florida + 3 more

Conditions: Urinary Bladder Neoplasms
Interventions: Durvalumab, Vicineum, Acetaminophen, Antihistamine, Bladder Biopsy, TURBT, Cystoscopy, Urine cytology, Electrocardiogram, CT, MRI; Drug · Procedure · Diagnostic Test
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiac Output, Sedation
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 1 Month to 18 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Congenital Heart Disease
Interventions: Cardiac Cath; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Umbilical Hernia
Interventions: Deflux; Device
Lead sponsor: South Shore Hospital; Other
Eligibility: 1 Year to 5 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: South Weymouth, Massachusetts

Conditions: Non Small Cell Lung Cancer
Interventions: Lobectomy; Procedure
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Invasive Ductal Carcinoma, Ductal Carcinoma in Situ
Interventions: Intra-operative Radiation Therapy - IORT; Radiation
Lead sponsor: Xoft, Inc.; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2029
U.S. locations: 22
States / cities: Tucson, Arizona • Duarte, California • Long Beach, California + 17 more

Conditions: Carotid Atherosclerosis, Peripheral Arterial Disease
Interventions: Not listed
Lead sponsor: Elucid Bioimaging Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Marrero, Louisiana • New Orleans, Louisiana

Conditions: Osteoarthritis
Interventions: Minimally Invasive Total Knee Arthroplasty [TKA Min], Total Knee Arthroplasty (TKA) Traditional; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years to 85 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: Boulder, Colorado • Denver, Colorado

Conditions: Breast Cancer Invasive, Early-stage Breast Cancer, High Risk Breast Carcinoma
Interventions: Azacitidine; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Paclitaxel, Eribulin, 5-Fluorouracil, Epirubicin, Cyclophosphamide, Doxorubicin; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Granulomatous Disease, Chronic, Job's Syndrome, Infection
Interventions: Posaconazole; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 2 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Kenilworth, New Jersey

Conditions: Spinal Cord Injuries, Spinal Cord Diseases
Interventions: RISES-T System; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Carcinoma in Situ, Transitional Cell Carcinoma, Non-muscle Invasive Bladder Cancer
Interventions: VALSTAR - Maintenance Therapy, No Maintenance treatment ( Standard of Care); Drug · Other
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 6
States / cities: Phoenix, Arizona • Denver, Colorado • Cumberland, Maryland + 3 more

Conditions: CT-guided Minimally Invasive Procedures e.g. Biopsies
Interventions: XACT Robotic System; Device
Lead sponsor: Xact Robotics Ltd.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Invasive Breast Carcinoma
Interventions: Best Practice, Exercise Intervention (home walking program and resistance training), Exercise Intervention (home-based Zumba program and resistance training), Exercise Intervention (HIIT program and resistance training), Informational Intervention, Laboratory Biomarker Analysis, Monitoring Device, Quality-of-Life Assessment, Questionnaire Administration; Other · Behavioral · Device
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: Not listed
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Down Syndrome, Edwards Syndrome
Interventions: Maternal blood screening test for fetal aneuploidy; Other
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 25
States / cities: Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 18 more

Conditions: Pterional Craniotomy
Interventions: Traditional pterional craniotomy, Osteoplastic craniotomy; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pregnancy, Labor
Interventions: LaborPro device; Device
Lead sponsor: Trig Medical Inc; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 650 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Blood Coagulation Disorders
Interventions: FFP Infusion; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 4 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 15
States / cities: Atlanta, Georgia • Iowa City, Iowa • Baltimore, Maryland + 11 more

Search by objective public record fields.

Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple Sclerosis

Intraperitoneal Infusion of Analgesic for Postoperative Pain Management

Ventricular Synchrony in Pediatric Patients

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation

A Study of Hemodynamic Cardiopulmonary Exercise for CHD

Minimally Invasive Closure of Umbilical Hernias

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Non-invasive Computer-Aided Phenotyping of Vasculopathy

Effectiveness of Minimally Invasive Total Knee Replacement in Improving Rehabilitation and Function

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Posaconazole to Treat Invasive Fungal Infections

Non-Invasive Electrical and Magnetic Neuromodulation in Persons With Chronic Spinal

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Evaluation of the XACT Robotic System for Image-guided Percutaneous Lung Procedures

Exercise in Improving Health and Quality of Life in Breast Cancer Survivors

Non-Invasive Screening for Fetal Aneuploidy

Effect of Craniotomy on Temporalis Function

Determination of Labor Progression Patterns Using Non-invasive, Ultrasound Based, Multiple Parameters

Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures